Skip to main content
TipRanks
Go Ultimate75% OFF

Vitura SA (VTR) AI Stock Analysis

2 Followers
FR:VTR

Vitura SA

(Paris:VTR)

Select Model
Rating:43Neutral
Price Target:EUR 3.00â–²(6.38% Upside)
Action:reiterated
Date:11/03/26

The score is weighed down primarily by below-average financial performance (multi-year net losses, reduced equity, and meaningful leverage) and bearish technicals (price below major moving averages with negative MACD). Valuation offers limited support because the company is loss-making (negative P/E) and no dividend yield is available.

Positive Factors
Revenue and EBIT RecoveryThe 2025 revenue rebound and return to positive EBIT indicate that the underlying operating platform can recover after weakness. If maintained, stronger activity could support earnings improvement and provide a more durable base for the company’s next several quarters.
Negative Factors
High LeverageDebt materially exceeds equity, leaving the company with a thin capital cushion if operating conditions weaken. This leverage can restrict financial flexibility, increase sensitivity to financing costs, and limit the ability to fund investment or absorb further asset or earnings deterioration.

Vitura SA (VTR) vs. iShares MSCI France ETF (EWQ)

-50%-40%-30%-20%-10%0%10%20%FR:VTR-38.70%EWQ+0.40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 48.11M
Dividend Yield
―
Average Volume (3M)
209
Price to Earnings (P/E)
-1.3
Beta (1Y)
0.68
Revenue Growth
8.96%
EPS Growth
41.13%
Country
France
Employees
2
Sector
Services
Sector Strength
55
Industry
REIT - Office

Vitura SA Business Overview & Revenue Model

Company Description

Established in 2006, Vitura operates as a publicly traded real estate investment trust (REIT), specifically designated as a "SIIC." The company's core strategy involves acquiring and managing premium office assets located within Paris and its broader...

How the Company Makes Money

Vitura makes money primarily through the sale and distribution of medicinal cannabis products and related services within the Australian regulated prescription market. Revenue is generated by supplying cannabinoid medicines (and associated product li...

Vitura SA Financial Statement Overview

Summary

Operations show some recovery (2025 revenue up strongly and EBIT positive), but financial quality remains pressured by repeated net losses, reduced equity, and a highly leveraged balance sheet. Cash flow is positive recently, yet relatively thin and volatile, limiting confidence in durability.

Income Statement

28Negative

Balance Sheet

44Neutral

Cash Flow

41Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue65.53M60.32M57.87M76.61M72.78M84.92M
Gross Profit34.80M37.76M32.91M50.43M44.14M63.67M
EBITDA5.71M21.86M26.85M-166.93M41.01M45.52M
Net Income-35.75M-20.75M-243.00M-239.85M-4.18M36.93M
Balance Sheet
Total Assets901.48M920.92M940.47M1.40B1.62B1.66B
Cash, Cash Equivalents and Short-Term Investments26.61M21.64M13.49M11.72M15.17M57.48M
Total Debt641.48M644.69M644.20M855.10M835.39M833.49M
Total Liabilities679.29M672.77M671.57M883.93M868.77M890.52M
Stockholders Equity222.19M248.15M268.91M511.91M755.44M772.94M
Cash Flow
Free Cash Flow5.07M3.99M3.83M-17.45M-22.70M-69.37M
Operating Cash Flow11.21M11.38M12.61M12.04M-9.36M40.90M
Investing Cash Flow-6.25M-7.51M-2.69M-29.32M-19.47M-103.31M
Financing Cash Flow-3.09M-1.06M-8.15M13.83M-13.48M57.05M

Vitura SA Technical Analysis

Technical Analysis SentimentNegative
Last Price2.82

Price Trends

50DMA3.56Negative
100DMA3.95Negative
200DMA3.97Negative

Market Momentum

MACD-0.21Negative
RSI43.43Neutral
STOCH60.78Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:VTR, the sentiment is Negative. The current price of 2.82 is above the 20-day moving average (MA) of 2.76, below the 50-day MA of 3.56, and below the 200-day MA of 3.97, indicating a neutral trend. The MACD of -0.21 indicates Negative momentum. The RSI at 43.43 is Neutral, neither overbought nor oversold. The STOCH value of 60.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:VTR.

Vitura SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

FR:VTR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:AUBFR:AUB73OutperformEUR 630.61M15.2314.17%3.02%27.45%19.70%
FR:COHFR:COH73OutperformEUR 42.30M13.2412.54%1.14%8.58%-18.77%
FR:ATEFR:ATE66NeutralEUR 3.02B21.476.19%1.73%0.11%-6.28%
FR:ALCGMFR:ALCGM60NeutralEUR 130.56M-9.05-5.44%―-0.98%―
Sector *55Neutral$13.29B17.4210.03%0.93%7.13%-12.93%
FR:VTRFR:VTR43NeutralEUR 48.11M-1.34-15.20%―8.96%41.13%
FR:ALCLAFR:ALCLA32UnderperformEUR 27.34M6.0910.38%―――

* Services Sector Average

Performance Comparison

-50%-25%0%25%FR:VTRFR:ATEFR:AUBFR:ALCLAFR:ALCGMFR:COHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:VTR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:VTRVitura SA2.82-1.80-38.96%
FR:ATEALTEN86.9519.5529.01%
FR:AUBAubay Société Anonyme49.650.982.01%
FR:ALCLAClaranova SA0.49-1.05-68.18%
FR:ALCGMCegedim SA9.68-2.42-20.00%
FR:COHCoheris7.02-7.39-51.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 02, 2026